Thalys(SH:603716) Xin Lang Cai Jing·2026-01-13 03:42Group 1 - The core point of the news is that Sely Medical has seen a significant stock price increase of 5.12% on January 13, reaching 30.58 CNY per share, with a total market capitalization of 6.428 billion CNY and a trading volume of 862 million CNY, indicating a 20.01% cumulative increase over three consecutive days [1] - Sely Medical, established on February 23, 2004, and listed on October 31, 2016, is based in Wuhan, Hubei Province, and specializes in medical testing services, agency of in vitro diagnostic products, and the research, production, and sales of its own in vitro diagnostic products [1] - The company's main business revenue composition includes IVD business at 39.91%, SPD business at 38.01%, and pure sales at 22.08% [1] Group 2 - From the perspective of Sely Medical's top ten circulating shareholders, a fund under GF Fund ranks among them, specifically the GF Healthcare Stock A (004851), which entered the top ten shareholders in the third quarter with 1.2236 million shares, accounting for 0.58% of circulating shares [2] - The GF Healthcare Stock A fund has a current scale of 5.185 billion CNY and has achieved a year-to-date return of 10.14%, ranking 1178 out of 5517 in its category, with a one-year return of 25.72%, ranking 3223 out of 4203 [2] - The fund manager, Wu Xingwu, has been in position for 10 years and 339 days, overseeing a total fund asset scale of 10.641 billion CNY, with the best fund return during his tenure being 102.67% and the worst being -38.11% [2]